Cargando…
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Breast cancer progression is a complex process controlled by genetic and epigenetic factors that coordinate the crosstalk between tumor cells and the components of tumor microenvironment (TME). Among those, the immune cells play a dual role during cancer onset and progression, as they can protect fr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991834/ https://www.ncbi.nlm.nih.gov/pubmed/33777750 http://dx.doi.org/10.3389/fonc.2021.610303 |
_version_ | 1783669251732668416 |
---|---|
author | Salemme, Vincenzo Centonze, Giorgia Cavallo, Federica Defilippi, Paola Conti, Laura |
author_facet | Salemme, Vincenzo Centonze, Giorgia Cavallo, Federica Defilippi, Paola Conti, Laura |
author_sort | Salemme, Vincenzo |
collection | PubMed |
description | Breast cancer progression is a complex process controlled by genetic and epigenetic factors that coordinate the crosstalk between tumor cells and the components of tumor microenvironment (TME). Among those, the immune cells play a dual role during cancer onset and progression, as they can protect from tumor progression by killing immunogenic neoplastic cells, but in the meanwhile can also shape tumor immunogenicity, contributing to tumor escape. The complex interplay between cancer and the immune TME influences the outcome of immunotherapy and of many other anti-cancer therapies. Herein, we present an updated view of the pro- and anti-tumor activities of the main immune cell populations present in breast TME, such as T and NK cells, myeloid cells, innate lymphoid cells, mast cells and eosinophils, and of the underlying cytokine-, cell–cell contact- and microvesicle-based mechanisms. Moreover, current and novel therapeutic options that can revert the immunosuppressive activity of breast TME will be discussed. To this end, clinical trials assessing the efficacy of CAR-T and CAR-NK cells, cancer vaccination, immunogenic cell death-inducing chemotherapy, DNA methyl transferase and histone deacetylase inhibitors, cytokines or their inhibitors and other immunotherapies in breast cancer patients will be reviewed. The knowledge of the complex interplay that elapses between tumor and immune cells, and of the experimental therapies targeting it, would help to develop new combination treatments able to overcome tumor immune evasion mechanisms and optimize clinical benefit of current immunotherapies. |
format | Online Article Text |
id | pubmed-7991834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79918342021-03-26 The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy Salemme, Vincenzo Centonze, Giorgia Cavallo, Federica Defilippi, Paola Conti, Laura Front Oncol Oncology Breast cancer progression is a complex process controlled by genetic and epigenetic factors that coordinate the crosstalk between tumor cells and the components of tumor microenvironment (TME). Among those, the immune cells play a dual role during cancer onset and progression, as they can protect from tumor progression by killing immunogenic neoplastic cells, but in the meanwhile can also shape tumor immunogenicity, contributing to tumor escape. The complex interplay between cancer and the immune TME influences the outcome of immunotherapy and of many other anti-cancer therapies. Herein, we present an updated view of the pro- and anti-tumor activities of the main immune cell populations present in breast TME, such as T and NK cells, myeloid cells, innate lymphoid cells, mast cells and eosinophils, and of the underlying cytokine-, cell–cell contact- and microvesicle-based mechanisms. Moreover, current and novel therapeutic options that can revert the immunosuppressive activity of breast TME will be discussed. To this end, clinical trials assessing the efficacy of CAR-T and CAR-NK cells, cancer vaccination, immunogenic cell death-inducing chemotherapy, DNA methyl transferase and histone deacetylase inhibitors, cytokines or their inhibitors and other immunotherapies in breast cancer patients will be reviewed. The knowledge of the complex interplay that elapses between tumor and immune cells, and of the experimental therapies targeting it, would help to develop new combination treatments able to overcome tumor immune evasion mechanisms and optimize clinical benefit of current immunotherapies. Frontiers Media S.A. 2021-03-11 /pmc/articles/PMC7991834/ /pubmed/33777750 http://dx.doi.org/10.3389/fonc.2021.610303 Text en Copyright © 2021 Salemme, Centonze, Cavallo, Defilippi and Conti http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Salemme, Vincenzo Centonze, Giorgia Cavallo, Federica Defilippi, Paola Conti, Laura The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy |
title | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy |
title_full | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy |
title_fullStr | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy |
title_full_unstemmed | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy |
title_short | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy |
title_sort | crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991834/ https://www.ncbi.nlm.nih.gov/pubmed/33777750 http://dx.doi.org/10.3389/fonc.2021.610303 |
work_keys_str_mv | AT salemmevincenzo thecrosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT centonzegiorgia thecrosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT cavallofederica thecrosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT defilippipaola thecrosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT contilaura thecrosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT salemmevincenzo crosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT centonzegiorgia crosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT cavallofederica crosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT defilippipaola crosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy AT contilaura crosstalkbetweentumorcellsandtheimmunemicroenvironmentinbreastcancerimplicationsforimmunotherapy |